Beconase Aq
Product manufactured by Glaxosmithkline Llc
Indications and Purposes
| Indications And Usage Beconase Aq Nasal Spray Is Indicated For The Relief Of The Symptoms Of Seasonal Or Perennial Allergic And Nonallergic (Vasomotor) Rhinitis. Results From 2 Clinical Trials Have Shown That Significant Symptomatic Relief Was Obtained Within 3 Days. However, Symptomatic Relief May Not Occur In Some Patients For As Long As 2 Weeks. Beconase Aq Nasal Spray Should Not Be Continued Beyond 3 Weeks In The Absence Of Significant Symptomatic Improvement. Beconase Aq Nasal Spray Should Not Be Used In The Presence Of Untreated Localized Infection Involving The Nasal Mucosa. Beconase Aq Nasal Spray Is Also Indicated For The Prevention Of Recurrence Of Nasal Polyps Following Surgical Removal. Clinical Studies Have Shown That Treatment Of The Symptoms Associated With Nasal Polyps May Have To Be Continued For Several Weeks Or More Before A Therapeutic Result Can Be Fully Assessed. Recurrence Of Symptoms Due To Polyps Can Occur After Stopping Treatment, Depending On The Severity Of The Disease. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Beclomethasone Dipropionate Monohydrate |